Evaluation of lipid profiles in patients treated with capecitabine


SÜRMELİOĞLU N. , PAYDAŞ S. , KARATAŞ Y. , SEYDAOĞLU G.

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.47, ss.1206-1209, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 47 Konu: 4
  • Basım Tarihi: 2017
  • Doi Numarası: 10.3906/sag-1607-53
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Sayfa Sayıları: ss.1206-1209

Özet

Background/aim: Capecitabine is a prodrug of 5-fluorouracil and has shown significant antitumor activity. The main adverse effects are hand-foot syndrome, diarrhea, and dermatitis. In recent years, hypertriglyceridemia has been reported in patients treated with capecitabine. Dyslipidemia is a rare but important side effect of capecitabine. The aim of this study is to examine the changes in lipid levels during capecitabine treatment and to raise awareness of pharmacovigilance.